JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 29 No. 10 1730-1737
© 1988 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorstad, B. L.
Right arrow Articles by Luke, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorstad, B. L.
Right arrow Articles by Luke, R. G.

Abnormal Captopril Renogram with a Technetium-99m-Labeled Hippuran Analog

Brett L. Thorstad, Charles D. Russell, Eva V. Dubovsky, Frederick S. Keller and Robert G. Luke

Division of Nuclear Medicine, Department of Radiology, Division of Nephrology, University of Alabama Hospital, and Birmingham V. A. Medical Center, Birmingham, Alabama

Correspondence: For reprints contact: Charles D. Russell, MD, PhD, Div. of Nuclear Medicine, University of Alabama Hospital, 619—19th Street South, Birmingham, AL 35233.

ABSTRACT

A case of renovascular hypertension is presented in which the [131I]hippuran renogram was initially normal, but became strikingly abnormal upon administration of the angiotensin converting enzyme (ACE) inhibitor captopril. The patient presented with fibromuscular dysplasia of the renal arteries, which was shown by hippuran renography to be functionally significant on the right side. She became normotensive after angioplasty of the right renal artery. Hypertension recurred a year later, at which time the renogram was normal without captopril, but showed functionally significant left renal artery stenosis with captopril challenge. Both the conventional agent, [131I] hippuran, and an expetimental new 99mTc-labaled hippuran analog, [99mTc]MAG3, were used. Angiography confirmed progression of disease on the left side, which was successfully treated by angioplasty. Functionally significant unilateral renal artery stenosis was thus demonstrated first on the right side and then, 1 yr later, on the left side, using hippuran and[99mTc]MAG3. Anatomic progression of disease was documented by angiography.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1988 by the Society of Nuclear Medicine.